Revolution Medicines, Inc. (RVMD)

NASDAQ: RVMD · Real-Time Price · USD

206.97

+1.82 (0.89%)

At close: Aug 10, 2026, 4:00 PM EDT

207.00

+0.03 (0.01%)

Pre-market: Aug 11, 2026, 6:26 AM EDT

Revolution Medicines Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-1,768	-1,131	-600.09	-436.37	-248.71	-187.09
Depreciation & Amortization	10.44	8.65	7.63	6.11	5.04	4.15
Stock-Based Compensation	269.24	118.39	79.2	61.77	31.2	20.72
Other Adjustments	227.89	19.7	-44.57	-18.84	1.56	6.31
Change in Receivables	-	-	1.25	3.42	1.26	0.46
Changes in Accounts Payable	19.05	9.54	-6.47	32.47	7.29	2.24
Changes in Accrued Expenses	154.37	112.27	21.99	14.67	1.5	8.72
Changes in Unearned Revenue	-	-	-	-4.46	-14.47	-1.66
Changes in Other Operating Activities	-70.19	-34.98	-16.37	-9.35	-9.06	-1.04
Operating Cash Flow	-1,223	-897.74	-557.44	-350.57	-224.4	-147.18
Operating Cash Flow Growth	-	-	-	-	-	-
Capital Expenditures	-9.1	-15.99	-10.31	-7.73	-10.82	-6.53
Purchases of Investments	-3,004	-1,795	-2,137	-1,059	-612.77	-671.34
Proceeds from Sale of Investments	1,626	1,929	1,593	724.05	599.47	535.75
Investing Cash Flow	-1,386	118.06	-554.39	-342.6	-24.12	-142.12
Issuance of Common Stock	646.17	377.09	863.71	392.39	301.39	294.6
Repurchase of Common Stock	-	-	-	-4.03	-	-
Net Common Stock Issued (Repurchased)	646.17	377.09	863.71	388.37	301.39	294.6
Other Financing Activities	238.52	244.44	95.71	840.83	0.04	-0.42
Financing Cash Flow	3,023	621.52	959.41	1,229	301.43	294.18
Net Cash Flow	413.94	-158.16	-152.42	536.03	52.92	4.88
Free Cash Flow	-1,232	-913.73	-567.74	-358.3	-235.22	-153.71
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-	-	-	-3094.14%	-664.83%	-522.99%
Free Cash Flow Per Share	-6.20	-4.81	-3.38	-3.17	-2.92	-2.11
Levered Free Cash Flow	-1,664	-1,052	-603.62	-404.65	-269.23	-181.21
Unlevered Free Cash Flow	-1,523	-1,103	-692.19	-451.57	-278.36	-182.12

SEC Filings: 10-K · 10-Q